PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSAIC HOLDINGS, INC. | 150 | $395 | 0.00% |
FMR LLC | 64,379 | $169,317 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 479,511 | $1,261,248 | 0.00% |
US BANCORP \DE\ | 200 | $526 | 0.00% |
FRANKLIN RESOURCES INC | 19,162 | $50,396 | 0.00% |
BANK OF AMERICA CORP /DE/ | 23,321 | $61,334 | 0.00% |
WELLS FARGO & COMPANY/MN | 295 | $776 | 0.00% |
NORTHERN TRUST CORP | 69,452 | $182,659 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 425,515 | $1,119,380 | 0.00% |
STATE STREET CORP | 162,482 | $427,328 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 200,000 | $526,000 | 0.00% |
CITIGROUP INC | 99,767 | $262,387 | 0.00% |
Tower Research Capital LLC (TRC) | 4,431 | $11,653 | 0.00% |
GOLDMAN SACHS GROUP INC | 84,144 | $221,299 | 0.00% |
MORGAN STANLEY | 338,821 | $891,100 | 0.00% |
External links
This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q3 2023. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.